Catalyst
Slingshot members are tracking this event:
GW Pharma (GWPH) Expects to Commence Phase 1 Clinical Program for Neonatal Hypoxic-Ischemic Encephalopathy (NHIE) Intravenous CBD in Q4 2016
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| GWPH |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 05, 2016
Occurred Source:
https://www.gwpharm.com/about-us/news/gw-pharmaceuticals-plc-reports-fourth-quarter-and-year-end-2016-financial-results-and
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Phase 1, Trial Initiation, Neonatal Hypoxic-ischemic Encephalopathy, Nhie, Intravenous Cbd
